Pharma Companies’ Increasing Use of Excipient GMP Certification Audit Reports

Time: 11:30 am - 12:00 pm

Date: 29 April 2020


This presentation covers why GMP/GDP audit reports of excipient suppliers are essential for pharma companies and why the availability of third-party audit reports has eased the audit burden and costs on both parties. The pre-requisites to utilising such certification audit reports and how they can help determine the qualification, scope, availability and best practices now increasingly being used as part of pharma company supplier qualification protocols is discussed.


« Back